Evaluation of the rodent micronucleus assay by a 28- day treatment protocol: Summary of the 13th collaborative study by the collaborative study group for the micronucleus test (CSGMT)/environmental mutagen society of japan (JEMS)-mammalian mutagenicity study group (MMS)

Environmental and Molecular Mutagenesis

Volumn 37, Issue 2, 2001, Pages 93-110

  Hamada, Shuichi ^a   Sutou, Sizuyo ^b   Morita, Takeshi ^c   Wakata, Akihiro ^d   Asanami, Shougo ^e   Hosoya, Satoko ^f   Ozawa, Shigenari ^g   Kondo, Koji ^h   Nakajima, Madoka ⁱ   Shimada, Hiroyasu ^j   Osawa, Koichi ^k   Kondo, Yasushi ^l   Asano, Norihide ^m   Sato, Sei Ichi ⁿ   Tamura, Hironobu ^o   Yajima, Nobuhiro ^p   Marshall, Richard ^q   Moore, Catherine ^r   Blakey, David H ^s   Schechtman, Leonard M ^t   Weaver, James L ^t   Torous, Dorothea K ^u   Proudlock, Ray ^v   Ito, Seiichi ^w   Namiki, Chiaki ^a   Hayashi, Makoto ^x   more..

^a SSP CO LTD   (Japan)

^b NATL INST BIOSCI HUM TECHNOL   (Japan)

^c Development and Medical Affairs Division   (Japan)

^d ASTELLAS PHARMA INC   (Japan)

^e OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^f Safety Research Institute for Chemical Compounds Co Ltd   (Japan)

^g KISSEI PHARMACEUTICAL CO LTD   (Japan)

^h SHIONOGI AND CO LTD   (Japan)

ⁱ An Pyo Center   (Japan)

^j DAIICHI SANKYO CO   (Japan)

^k TAISHO PHARMACEUTICAL CO LTD   (Japan)

^l MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^m NITTO DENKO CORPORATION   (Japan)

ⁿ JAPAN TOBACCO INC   (Japan)

^o NIPPON SHINYAKU CO LTD   (Japan)

^p SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

^q UK   (United Kingdom)

^r ASTRAZENECA   (United Kingdom)

^s HEALTH CANADA   (Canada)

^t Office of the Commissioner of Food and Drugs   (United States)

^u LITRON LABORATORIES   (United States)

^v HUNTINGDON LIFE SCIENCES   (United Kingdom)

^w Nippon Experimental Medical Research Institute Company Ltd   (Japan)

^x NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

more..

Author keywords

28 day treatment; CSGMT; Micronucleus assay; Mouse; Rat

Indexed keywords

1,2 DIMETHYLHYDRAZINE; AZIRIDINE DERIVATIVE; BENZO[A]PYRENE; COLCHICINE; CYCLOPHOSPHAMIDE; CYTARABINE; ENVIRONMENTAL MUTAGEN; MERCAPTOPURINE; MESYLIC ACID METHYL ESTER; MITOMYCIN C; MONOCROTALINE; N (2 FLUORENYL)ACETAMIDE; PHENACETIN; POTASSIUM BROMATE; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BONE MARROW; CONTROLLED STUDY; DOSE CALCULATION; EXTRAMEDULLARY HEMATOPOIESIS; FLOW CYTOMETRY; HYPOTHERMIA; HYPOXIA; JAPAN; LIVER; MALE; MICRONUCLEUS TEST; MOUSE; NONHUMAN; RAT; RETICULOCYTE; SPLEEN FUNCTION;

ANIMALS; MALE; MICRONUCLEUS TESTS; MUTAGENS; RATS;

MAMMALIA; RODENTIA;

EID: 0035070535     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.1017     Document Type: Article

References (49)

1. Micronuclei induced in peripheral blood of Em-PIM-1 transgenic mice by chronic oral treatment with 2-acetylaminofluorene or benzene but not with diethylnitrosamine or 1,2-dichloroethane
2. Detection of micronuclei in rat peripheral blood following oral administration of benzene for 14 days
3. Hypothermia induces micronuclei in mouse bone marrow cells
4. Hypothermia induces micronuclei in mice
5. The suitability of rat peripheral blood in subchronic studies for the micronucleus assay
6. Transient hypothermia induces micronuclei in mice
7. The mutagenic activity of 61 agents as determined by the micronucleus, salmonella, and sperm abnormality assays
8. Induction of micronuclei by benzene in B6C3F1 mice: Retrospective analysis of peripheral blood smears from the NTP carcinogenesis bioassay
9. Sex difference in the micronucleus test
10. Strain difference in the micronucleus test
11. Single versus multiple dosing in the micronucleus test: The summary of the fourth collaborative study by CSGMT/JEMS-MMS
12. Micronucleus test with mouse peripheral blood erythrocytes by acridine orange supravital staining: The summary report of the 5th collaborative study by CSGMT/JEMS-MMS
13. Protocol recommended by the CSGMT/JEMS-MMS for the short-term mouse peripheral blood micronucleus test
14. Individual data in the results of 7th collaborative study organized by the CSGMT/JEMS-MMS
15. Simple and reliable enumeration of micronucleated reticulocytes with a single-laser flow cytometer
16. Cytogenetic analysis of mice chronically fed the food mutagen 2-amino-1-methyl-6-phenylimidzo[4,5b]pyridine
17. The in vivo rat micronucleus test: Integration with a 14-day study
18. Effect of aging on mouse micronucleus test results: A report of the 8th collaborative study organized by the CSGMT/JEMS-MMS
19. Induction of micro-nucleated erythrocytes by erythropoietin
20. An application of acridine orange fluorescent staining to the micronucleus test
21. Difference between intraperitoneal and oral garage application in the micronucleus test, the 3rd collaborative study by CSGMT/ JEMS-MMS
22. The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides
23. The micronucleus assay using peripheral blood reticulocytes from mitomycin C- and cyclophosphamide-treated rats
24. Induction of micronuclei in rat bone marrow and peripheral blood following acute and subchronic treatment of azathioprine
25. Lifetime micronucleus frequencies in MS/Ae mice treated with mitomycin C: A report of the 8th collaborative study organized by the CSGMT/JEMS-MMS
26. Macrocytic-megaloblastic anemia in male B6C3F1 mice following chronic exposure to 1,3-butadiene
27. Absorption, distribution and excretion of tacrolimus (FK506) in the baboon
28. 1,3-Butadiene: Induction of micronucleated erythrocytes in the peripheral blood of B6C3F1 mice exposed by inhalation for 13 weeks
29. Studies on the metabolic fate of NK-104, a new inhibitor of HMG-CoA reductase (1): Absorption, distribution, metabolism and excretion in rats
30. Selection of mutagenicity and cell transformation test - Interpretation of results
31. Micronucleus assay protocols
32. The in vivo erythrocyte micronucleus test: Measurement at steady state increases assay efficiency and permits integration with toxicity studies
33. Integration of cytogenetic assays with toxicology studies
34. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (Groups 1, 2A, and 2B): The summary report of the 6th collaborative study by CSGMT/JEMS-MMS
35. Effects of anoxia on chromosomal aberration
36. Studies on the metabolic fate of D0870, a new triazole antifungal agent: Tissue distribution of radioactivity and unchanged compound in rats after single and multiple oral administration of [14C]D0870
37. Metabolic fate of novel antiulcer agent, T-593(III): Blood concentration, distribution, metabolism, excretion and effects on hepatic drug metabolizing enzyme system after repeated oral administration to rats
38. Effect of aging on spontaneous micronucleus frequencies in peripheral blood of several strains of mouse by the acridine orange supravital staining
39. The persistence of micronuclei in peripheral blood erythrocytes: Detection of chronic chromosome breakage in mice
40. The persistence of micronucleated erythrocytes in the peripheral circulation of normal and splenectomized Fisher 344 rats: Implications for cytogenetic screening
41. Assessment of cytogenetic damage by quantitation of micronuclei in human peripheral blood erythrocytes
42. The micronucleus test of benzo[a]pyrene with mouse and rat peripheral blood reticulocytes
43. The micronucleus test and erythropoiesis: Effects of erythropoietin and mutagen on the ratio of polychromatic to normochromatic erythrocytes (P/N ratio)
44. Comparative cytogenetic analysis of bone marrow damage induced in male B6C3F1 mice by multiple exposures to gaseous 1,3-butadiene
45. Evaluation of the rat micronucleus test with bone marrow and peripheral blood: Summary of the 9th collaborative study by CSGMT/JEMS-MMS
46. Phenolphthalein: Induction of micronucleated erythrocytes in mice
47. Induction of micronucleated erythrocytes by recombinant human erythropoietin
48. Genotoxicity of genetic recombinant human erythropoietin in a novel test system
49. Comparative studies in induction of micronuclei by three genetically recombinant and urinary human erythropoietins